Rankings
▼
Calendar
REVB Q3 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$868
Net Income
-$868
EPS (Diluted)
$-1.51
QoQ Revenue Growth
NaN%
Balance Sheet
Total Assets
$3M
Total Liabilities
$3M
Stockholders' Equity
$12,813
Cash & Equivalents
$3M
← FY 2020
All Quarters
Q4 2020 →
